drugset / Trial / NCT05649111

A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification

NCT05649111

Phase 4 Unknown 20 enrolled Kafrelsheikh University
RandomizedParallel-groupTriple-blindTreatment

Summary

The study aims at detecting the minimum effective daily dose and duration of difluprednate that can be used to treat postoperative inflammation after phacoemulsification without increasing the intraocular pressure, and whether it can be safely given within the first 24 hours after the operation.

Timeline

Start
2022-11-01
Primary completion
2023-02-01
Completion
2023-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Difluprednate Small molecule Other

Indications